Quick Answer
PLUS THERAPEUTICS, INC. reported Long Term Debt of $3.79 million for the year ending 2022.
- PLUS THERAPEUTICS, INC. showed a decrease of -24.4% in Long Term Debt from 2021 to 2022.
- This data is from PLUS THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2024.
- XBRL data for this metric is available from 2021 to 2022 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $4.72 million | Q2 2022: $4.42 million | Q3 2022: $4.11 million.
- Historical annual values: Fiscal year 2022: $3.79 million | Fiscal year 2021: $5.01 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: